Lee Ainslie Homology Medicines, Inc. Transaction History

Maverick Capital LTD

  • $4.82 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$18.39 - $26.3 $3.06 Million - $4.37 Million
-166,249 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$15.54 - $22.86 $8.68 Million - $12.8 Million
-558,794 Reduced 77.07%
166,249 $3.8 Million
Q2 2018

Aug 14, 2018
BUY
$16.49 - $21.55 $119,552 - $156,237
7,250 Added 1.01%
725,043 $14.3 Million
Q1 2018

May 15, 2018
BUY
$18.66 - $18.7 $13.4 Million - $13.4 Million
717,793 New
717,793 $12.4 Million

Others Institutions Holding FIXX

# of Institutions
3
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email